Rossby Financial’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.87K Buy
194
+68
+54% +$2.01K ﹤0.01% 1310
2026
Q1
$3.51K Buy
126
+36
+40% +$925 ﹤0.01% 1627
2025
Q4
$1.95K Sell
90
-9,910
-99% -$196K ﹤0.01% 1372
2025
Q3
$158K Hold
10,000
0.05% 318
2025
Q2
$113K Buy
+10,000
New +$108K 0.04% 346

Other funds holding ROIV

Rossby Financial's ROIV Position: Q2 2026 in Review

Rossby Financial increased its Roivant Sciences (ROIV) stake by 54% in Q2 2026, buying an estimated $2.01K and bringing the position to 194 shares worth $6.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

Rossby Financial first reported a position in ROIV in Q2 2025 and has held it in 5 quarters since. The position peaked at $158K in Q3 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Rossby Financial held 194 shares of Roivant Sciences worth $6.87K as of Q2 2026.
  • Rossby Financial bought 68 Roivant Sciences shares in Q2 2026, an estimated $2.01K.
  • Roivant Sciences made up ﹤0.01% of Rossby Financial's portfolio in Q2 2026, its #1310 holding.
  • Rossby Financial first reported a position in Roivant Sciences in Q2 2025 and has held it in 5 quarters since.
  • Rossby Financial's Roivant Sciences position peaked at $158K in Q3 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.